American Gene Technologies
American Gene Technologies is a clinical-stage biotechnology company based in Rockville, Maryland, specializing in gene therapy to address serious diseases, including HIV, cancer, and phenylketonuria (PKU). The company is at the forefront of developing innovative therapies and has received FDA Orphan Drug Approval, highlighting its commitment to advancing medical breakthroughs.
With a rapidly growing pipeline and a focus on curing diseases rather than merely treating them, American Gene Technologies is poised to disrupt the pharmaceutical landscape. The company aims to cut the time and costs associated with drug development, tapping into a potential $5 trillion market by leveraging its patented gene therapy technologies.
Generated from the website